BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

Was Investor Ready for T+1?

Citi Pharma to list Citi Veterinary Pharma, targets Rs2bn IPO

PSX Closing Bell: The Climb Begins Again

Name	Price/Vol	%Chg/NChg
KSE100	157,453.90 177.22M	0.20% 321.81
ALLSHR	93,770.28 260.46M	0.22% 203.42
KSE30	48,366.39 50.95M	0.13% 63.41
KMI30	221,955.25 47.63M	0.52% 1156.73
KMIALLSHR	60,333.59 118.35M	0.58% 345.06
BKTi	45,935.26 14.84M	-0.56% -257.82
OGTi	30,508.99 8.27M	1.05% 315.88

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	68,140.00	69,160.00 67,615.00	-325.00 -0.47%
BRENT CRUDE	82.64	82.77 81.28	1.24 1.52%
RICHARDS BAY COAL MONTHLY	99.40	0.00 0.00	-7.85 -7.32%
ROTTERDAM COAL MONTHLY	124.15	139.50 124.15	5.35 4.50%
USD RBD PALM OLEIN	1,083.50	1,083.50 1,083.50	0.00 0.00%
CRUDE OIL - WTI	75.50	75.70 74.37	0.94 1.26%
SUGAR #11 WORLD	13.95	14.20 13.91	0.04 0.29%